Wu Xu, Wang Honglei, Li Chenlong, Zhu Yaying, Wang Qixuan, Zhang Tianyu, Fu Yaoyao, He Aijuan
Department of Facial Plastic and Reconstructive Surgery, Eye and ENT Hospital, Fudan University, Shanghai, China.
ENT Institute, Eye and ENT Hospital, Fudan University, Shanghai, China.
Mater Today Bio. 2025 Aug 16;34:102203. doi: 10.1016/j.mtbio.2025.102203. eCollection 2025 Oct.
Cartilage defects, whether congenital or acquired, are highly prevalent in clinical practice. Tissue engineering offers a promising strategy for cartilage regeneration; however, the loss of chondrocyte phenotype during expansion remains a major barrier to the clinical translation of chondrocyte-based engineered cartilage. Emerging evidence has highlighted that alterations in chondrocyte metabolic states can profoundly impact their phenotypic stability. Nonetheless, how metabolic patterns shift during expansion, and whether metabolic modulation can stabilize the chondrocyte phenotype, remain insufficiently explored. To address these questions, we first utilized single-cell RNA sequencing combined with bulk transcriptomic analysis to profile the metabolic reprogramming of chondrocytes during expansion. Our findings revealed a distinct shift from glycolytic metabolism toward oxidative phosphorylation dominance. Based on this insight, we engineered a DN (double-net) hydrogel scaffold composed of collagen, PEG (polyethylene glycol), and CNF (nanocellulose). To endow the scaffold with antioxidant functionality, TA (tannic acid) was incorporated by hydrogen bonding to the CNF network, forming an antioxidant DN-TA hydrogel system. To evaluate whether attenuating aerobic metabolism could preserve chondrocyte phenotype, P3 (passage 3) chondrocytes were cultured within the hydrogel scaffold and then implanted subcutaneously into nude mice. The DN-TA hydrogel effectively preserved the chondrocyte phenotype by activating HIF-1 signaling pathway and reducing ROS (reactive oxygen species). Furthermore, after 8/12 weeks of subcutaneous implantation, the DN-TA scaffold significantly enhanced cartilage regeneration, as evidenced by increased extracellular matrix deposition and more mature cartilage formation. Collectively, our study demonstrates that reducing aerobic metabolism helps stabilize the chondrocyte phenotype and promotes functional cartilage regeneration. These findings offer novel insights for optimizing cartilage tissue engineering strategies through metabolic modulation.
软骨缺损,无论是先天性的还是后天获得性的,在临床实践中都非常普遍。组织工程为软骨再生提供了一种有前景的策略;然而,在扩增过程中软骨细胞表型的丧失仍然是基于软骨细胞的工程化软骨临床转化的主要障碍。新出现的证据表明,软骨细胞代谢状态的改变会深刻影响其表型稳定性。尽管如此,在扩增过程中代谢模式如何转变,以及代谢调节是否能稳定软骨细胞表型,仍未得到充分探索。为了解决这些问题,我们首先利用单细胞RNA测序结合大量转录组分析来描绘软骨细胞在扩增过程中的代谢重编程。我们的研究结果揭示了从糖酵解代谢向氧化磷酸化主导的明显转变。基于这一见解,我们设计了一种由胶原蛋白、聚乙二醇(PEG)和纳米纤维素(CNF)组成的双网(DN)水凝胶支架。为了赋予支架抗氧化功能,通过氢键将单宁酸(TA)掺入CNF网络中,形成一种抗氧化DN-TA水凝胶系统。为了评估减弱有氧代谢是否能保留软骨细胞表型,将第3代(P3)软骨细胞培养在水凝胶支架内,然后皮下植入裸鼠体内。DN-TA水凝胶通过激活缺氧诱导因子-1(HIF-1)信号通路和减少活性氧(ROS)有效地保留了软骨细胞表型。此外,皮下植入8/12周后,DN-TA支架显著增强了软骨再生,细胞外基质沉积增加和更成熟的软骨形成证明了这一点。总的来说,我们的研究表明,减少有氧代谢有助于稳定软骨细胞表型并促进功能性软骨再生。这些发现为通过代谢调节优化软骨组织工程策略提供了新的见解。